🇺🇸 FDA
Patent

US 11028083

Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases

granted A61KA61K45/06A61P

Quick answer

US patent 11028083 (Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases) held by The Board of Regents of the University of Texas System expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
36
CPC classes
A61K, A61K45/06, A61P, A61P3/00, A61P35/02